GSK3732394: a Multi-specific Inhibitor of HIV Entry

Journal of Virology
David WenselMark Krystal

Abstract

Long-acting antiretrovirals could provide a useful alternative to daily oral therapy for HIV-1-infected individuals. Building on a bi-specific molecule with adnectins targeting CD4 and gp41, a potential long-acting biologic, GSK3732394, was developed with three independent and synergistic modes of HIV entry inhibition that potentially could be self-administered as a long-acting subcutaneous injection. Starting with the bi-specific inhibitor, an α-helical peptide inhibitor was optimized as a linked molecule to the anti-gp41 adnectin, with each separate inhibitor exhibiting at least single-digit nanomolar (or lower) potency and a broad spectrum. Combination of the two adnectins and peptide activities into a single molecule was shown to have synergistic advantages in potency, the resistance barrier, and the ability to inhibit HIV-1 infections at low levels of CD4 receptor occupancy, showing that GSK3732394 can work in trans on a CD4+ T cell. Addition of a human serum albumin molecule prolongs the half-life in a human CD4 transgenic mouse, suggesting that it may have potential as a long-acting agent. GSK3732394 was shown to be highly effective in a humanized mouse model of infection. GSK3732394 is currently in clinical trials.IMPOR...Continue Reading

References

Dec 5, 1998·Journal of Molecular Biology·A KoideS Koide
Mar 7, 2001·Science·M J RootP S Kim
Dec 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ping ZhuKenneth H Roux
Mar 30, 2005·Expert Opinion on Pharmacotherapy·Adriano Lazzarin
Jul 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·John J DwyerMary K Delmedico
Mar 20, 2009·Proceedings of the National Academy of Sciences of the United States of America·Paolo IngallinellaAntonello Pessi
Jun 6, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Roland E Kontermann
Nov 12, 2010·Protein Engineering, Design & Selection : PEDS·D Lipovsek
Jan 13, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anthony W TolcherMonica Mita
Jan 11, 2012·Methods in Enzymology·Shohei KoideDaša Lipovšek
Jul 24, 2013·Proceedings of the National Academy of Sciences of the United States of America·Craig S PaceDavid D Ho
Jan 28, 2014·The Journal of Antimicrobial Chemotherapy·Marcelo T AugustoNuno C Santos
Dec 5, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·William SpreenStephen Piscitelli
Jan 2, 2015·AIDS Research and Therapy·Gloria Huerta-GarcíaJesús Gaytán-Martínez
Jan 9, 2015·PLoS Pathogens·Oliver F BrandenbergAlexandra Trkola
Jun 6, 2015·Current Oncology Reports·Esha SachdevMonica Mita
Feb 18, 2016·Drugs·Sean G KellyBabafemi O Taiwo
Mar 10, 2016·Current HIV Research·Hyun A YiAmy Jacobs
Oct 30, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ruijiang SongDavid D Ho
Jun 7, 2017·Antimicrobial Agents and Chemotherapy·David WenselJonathan Davis
Mar 30, 2018·Journal of Virology·Ina FetzerMichael Farzan
Aug 31, 2018·Retrovirology·Neal N PadteDavid D Ho
Oct 20, 2018·Nature Immunology·Devin Sok, Dennis R Burton
Nov 23, 2018·Drug Design, Development and Therapy·Katya C CoradoEric S Daar
Feb 2, 2019·Nature Immunology·Devin Sok, Dennis R Burton
Mar 20, 2019·Antimicrobial Agents and Chemotherapy·Mario V BeccariWesley D Kufel
Apr 3, 2019·Nature Medicine·Marina CaskeyMichel C Nussenzweig
May 10, 2019·Journal of Virology·Christoph H FellingerMichael Farzan

❮ Previous
Next ❯

Citations

Jun 26, 2020·MMW Fortschritte der Medizin·Eva Wolf, Sebastian Noe
Dec 23, 2020·Human Gene Therapy·Tatjana I CornuToni Cathomen
Feb 23, 2021·The Journal of Biological Chemistry·Peter G ChandlerAshley M Buckle
Jun 25, 2021·Chemical Society Reviews·Golnaz KamaliniaRichard W Roberts
Oct 5, 2021·Chembiochem : a European Journal of Chemical Biology·Susanne HuhmannBeate Koksch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.